Subcutaneous Fat Clinical Trial
Official title:
Allergan IIT-2019-10713 Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis
The purpose of this study is to evaluate the safety and efficacy of cryolipolysis of the medial infragluteal fold to create the appearance of a gluteal lift.
In this study, the safety and the efficacy of ZELTIQ's technology will be evaluated for the non-invasive fat reduction of the medial infragluteal folds on a small group of subjects. This is a feasibility study to determine if cryolipolysis in this area produces a desirable lifted appearance to the buttocks. Typically, a lifted more youthful appearance is obtained through surgical means. Study participants will be recruited from the population of patients who have suitable, treatable subcutaneous fat on the medial infragluteal folds and desire a lifted appearance. Subjects will receive treatments with a cooled cup cryolipolysis applicator from the CoolAdvantage family of applicators (cooled cup vacuum applicator). Treatments will be performed with a treatment temperature of - 11°C for up to 35 minutes. Subjects will complete all study-required follow-up visits, including an 8-week follow-up which may include a second treatment session, as well as a 12-week post final treatment follow-up visit. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04699669 -
A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02512822 -
Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring
|
N/A | |
Active, not recruiting |
NCT06005441 -
A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
|
Phase 2 | |
Active, not recruiting |
NCT05736107 -
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
|
Phase 2 | |
Not yet recruiting |
NCT03160976 -
Cryolipolysis on Localized Adiposity
|
N/A | |
Completed |
NCT03871556 -
Diagnostic Ultrasound for Measuring Fat of the Body
|
N/A | |
Completed |
NCT02098811 -
Evaluation of the Safety and Precursors of Efficacy
|
N/A | |
Completed |
NCT02539043 -
Effects of Ultrasound Cavitation Focused on Located Adiposity
|
N/A | |
Completed |
NCT01842802 -
Clinical Investigation of Non Invasive Fat Reduction
|
N/A | |
Completed |
NCT04698642 -
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat
|
Phase 2 | |
Completed |
NCT02052622 -
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
|
Phase 3 | |
Completed |
NCT04897412 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
|
Phase 2 | |
Completed |
NCT03682471 -
Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
|
||
Completed |
NCT05234736 -
A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
|
Phase 2 | |
Completed |
NCT04575467 -
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
|
Phase 2 |